Work

EP991 Exceptional response with combined anti-hormone and MEK inhibitor therapy in a patient with hormone receptor-positive ovarian cancer and isolated KRAS alteration. Implications for a precision medicine strategy

Year: 2019

Type: conference-abstract

Source: International Journal of Gynecological Cancer

DOI: 10.1136/ijgc-2019-esgo.1035

Authors: K. Takahashi, S. Kato, K. Bamel, S. Ikeda, S. Plaxe, B. Parker, R. Kurzrock

Institutions: Tokyo Medical and Dental University, Institute of Science Tokyo Hospital, Moores Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2988206874

Cites:

Cited by:

Related to: 10